Literature DB >> 24297591

Typical and atypical pattern of pulmonary sarcoidosis at high-resolution CT: relation to clinical evolution and therapeutic procedures.

Roberta Polverosi1, Rosangela Russo, Alessandro Coran, Anna Battista, Carlo Agostini, Fabio Pomerri, Chiara Giraudo.   

Abstract

AIM: This study was done to evaluate the importance of high-resolution CT (HRCT) in defining pattern and extent of disease and establishing the clinical and therapeutic pathway in sarcoidosis.
MATERIALS AND METHODS: A retrospective analysis of 56 patients with pulmonary involvement of sarcoidosis was performed. Two groups were identified: 39 patients exhibiting a typical HRCT pattern and 17 patients with an atypical pattern. Inclusion criteria were the presence of radiological documentation (HRCT) of disease, clinical and radiological follow-up of 1 year and the beginning of any therapy within 1 month from the diagnosis.
RESULTS: Among subjects not receiving therapy, the comparison between the two groups showed that the radiological findings remained stable in subjects with a typical pattern, while they worsened in more than 70% of cases with atypical appearance. Therapy was more effective in patients with a typical pattern. Recurrences occurred in both groups, but more often in patients with a typical pattern. One patient not receiving treatment experienced clinical worsening. Re-evaluation of HRCT within 1 year revealed no correlation between clinical deterioration and radiological changes.
CONCLUSIONS: The findings of this study suggest that persistence of the inflammatory process rather than the radiological pattern at onset is a prognostic factor for recurrence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297591     DOI: 10.1007/s11547-013-0356-x

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

1.  Large coalescent parenchymal nodules in pulmonary sarcoidosis: "sarcoid galaxy" sign.

Authors:  Masashi Nakatsu; Hiroto Hatabu; Kenji Morikawa; Hidemasa Uematsu; Yoshiharu Ohno; Koichi Nishimura; Sonoko Nagai; Takateru Izumi; Junji Konishi; Harumi Itoh
Journal:  AJR Am J Roentgenol       Date:  2002-06       Impact factor: 3.959

Review 2.  Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation.

Authors:  Eva Criado; Marcelo Sánchez; José Ramírez; Pedro Arguis; Teresa M de Caralt; Rosario J Perea; Antonio Xaubet
Journal:  Radiographics       Date:  2010-10       Impact factor: 5.333

3.  Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis.

Authors:  S J Lewis; G M Ainslie; E D Bateman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1999-03       Impact factor: 0.670

4.  Therapy for extrapulmonary sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Semin Respir Crit Care Med       Date:  2002-12       Impact factor: 3.119

Review 5.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

6.  The computed tomographic spectrum of thoracic sarcoidosis.

Authors:  J E Kuhlman; E K Fishman; U M Hamper; M Knowles; S S Siegelman
Journal:  Radiographics       Date:  1989-05       Impact factor: 5.333

7.  Normal chest roentgenograms in chronic diffuse infiltrative lung disease.

Authors:  G R Epler; T C McLoud; E A Gaensler; J P Mikus; C B Carrington
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

8.  Thoracic sarcoidosis: radiologic-pathologic correlation.

Authors:  B H Miller; M L Rosado-de-Christenson; H P McAdams; N F Fishback
Journal:  Radiographics       Date:  1995-03       Impact factor: 5.333

9.  The clinical and radiologic features of nodular pulmonary sarcoidosis.

Authors:  Subramanian Malaisamy; Bhavinkumar Dalal; Christian Bimenyuy; Ayman O Soubani
Journal:  Lung       Date:  2008-10-09       Impact factor: 2.584

10.  Pulmonary sarcoidosis: changes on follow-up CT examination.

Authors:  J Murdoch; N L Müller
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

View more
  6 in total

1.  Mediastinal widening and miliary chest radiograph pattern in a middle aged man: could it be sarcoidosis?

Authors:  Clementine Bostantzoglou; Konstantinos Samitas; Charalampos Gkogkou; Eleftherios Zervas; Mina Gaga
Journal:  BMJ Case Rep       Date:  2014-07-17

Review 2.  From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.

Authors:  Catherine A Bonham; Mary E Strek; Karen C Patterson
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

3.  TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis.

Authors:  M Facco; A Cabrelle; F Calabrese; A Teramo; F Cinetto; S Carraro; V Martini; F Calzetti; N Tamassia; M A Cassatella; G Semenzato; C Agostini
Journal:  Clin Mol Allergy       Date:  2015-08-03

4.  Predominant diffuse ground glass opacity in both lung fields: A case of sarcoidosis with atypical CT findings.

Authors:  Chunmei Ma; Yadong Zhao; Taihua Wu
Journal:  Respir Med Case Rep       Date:  2016-01-22

5.  Morphological Patterns of Sarcoidosis and Clinical Outcome: Retrospective Analysis through a Multidisciplinary Approach.

Authors:  Giulio Distefano; Ada Vancheri; Monica Palermo; Francesco Tiralongo; Pietro Valerio Foti; Letizia Antonella Mauro; Carlo Vancheri; Antonio Basile; Stefano Palmucci
Journal:  Diagnostics (Basel)       Date:  2020-04-11

6.  Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT.

Authors:  Jianghui Duan; Yanyan Xu; Haixu Zhu; Haibo Zhang; Shilong Sun; Hongliang Sun; Wu Wang; Sheng Xie
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.